MEDICAL ROBOTIC SYSTEM MARKET ANALYSIS

Medical Robotic System Market Size and Trends

Global medical robotic system market is estimated to be valued at USD 21.3 Bn in 2024 and is expected to reach USD 63.1 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 16.8% from 2024 to 2031.

To learn more about this report, request sample copy

Rising demand for automation in the healthcare sector and rising investment in medical robot research and development can drive the market growth over the forecast period.The market is witnessing several innovations that are expanding medical robot applications in areas like surgery, rehabilitation and elderly assistance. Surgical robots have emerged as a vital part of minimally invasive surgery and their use is being explored for applications beyond gynaecology and urology. With continuous technological advancements, medical robotic systems are becoming more affordable and user-friendly.

Rising demand for minimally invasive surgery

Growing aging population and rising prevalence of chronic diseases can boost demand for surgical procedures. Patients prefer surgical options that reduce treatment time and promote faster recovery. Minimally invasive surgery addresses both these needs by utilizing specialized robotic systems that allow surgeons to perform complex operations through small incisions instead of conventional open surgery. Robotic systems provide surgeons with enhanced visualization, improved dexterity and accuracy through their automated surgical arms. This translates to less post-surgical pain and trauma for patients, shorter hospital stays and lower risks of surgical site infections as compared to open surgeries. The benefits of robotic surgery have been widely recognized in procedures like organ transplants, cardiac bypass, prostatectomy for prostate cancer treatment and hysterectomies. More hospitals and healthcare facilities are now equipping their operating rooms with robotic surgical systems to meet the growing demand and stay competitive. For instance, in March 2023, Apollo Hospitals completed 10,000 surgeries using robotic assistance. A recent press statement reveals a remarkable surge, with a more than 400% increase in robotic-assisted procedures performed over the past two years across their hospitals in India. The healthcare provider has also expanded robotic-assisted procedures to more than 20 specialties, solidifying its position as a leader in advanced surgical solutions in the country.

Market Concentration and Competitive Landscape

To learn more about this report, request sample copy

Technological advances expanding applications

Constant technological innovation broadens the scope of medical robotic systems. Newer generations of robotic platforms feature more sophisticated sensory and imaging capabilities, more dexterous surgical tools as well as built-in intelligence and machine learning. Advancements in areas like computer vision, virtual reality simulation, autonomous navigation and human-robot interface design empowers robots to take on increasingly complex surgical tasks. Miniaturization of robotics technology enables new flexible and modular systems that can navigate the human body through small access points. As robotic systems gain enhanced abilities, new surgical applications that were previously not possible are emerging. Areas witnessing expanding roles of robotics include transoral surgeries, natural orifice translumenal endoscopic surgery (NOTES), less invasive brain surgeries and interventional radiology procedures. Robotics assist rehabilitation therapies through tasks like stroke recovery training. With continuous evolution in robotics and AI, entirely new medical procedures and treatment paradigms are expected to emerge.

Key Takeaways from Analyst

Global medical robotic systems market growth is driven by rising healthcare costs and the need for minimally invasive surgery. Increasing geriatric population, those are prone to diseases, can boost demand for surgical robots that can perform complex procedures with more accuracy and reliability. Technologies like 3D vision systems, miniaturized instruments and advanced motion sensors allows greater adoption of robotics in areas like radiotherapy, prosthesis development and rehabilitation.

High costs of robotic systems can hamper its widespread adoption in cost-sensitive markets. Given the capital expenditure and maintenance costs involved, long term return on investment is crucial for healthcare providers to invest in such technologies. Skill development challenges for training surgeons to use robots and program them also impact the market growth.

North America currently dominates the market due to presence of major players and rising popularity of robotic surgeries in the region. However, Asian markets like China, Japan and India are expected to witness fastest growth due to increasing medical tourism, infrastructure spend and government initiatives for widespread healthcare access. Medical robotic systems with cloud-based capabilities can witness huge adoption, if data connectivity and security issues are addressed.

Market Challenges: High costs associated with medical robotic systems

The high costs associated with medical robotic systems can hamper the global medical robotic systems market growth. Robotic surgical systems are quite expensive  due to the high-end computer systems, miniaturized surgical tools, motion sensors and other precision technologies incorporated in these robots. Regular maintenance and upgrade of these sophisticated machines also involves recurring costs over the lifespan. Due to substantial capital requirement, not every hospital, especially those in developing nations, can afford to invest in such expensive equipment. Training and education of operating room staff, surgeons and other clinical personnel in the functions, set-up and operation of these robotic systems adds to the overall costs. Extensive practice is required on simulator platforms before performing on actual patients. The time and monetary resources invested are not recoverable in the short term. This discourages many healthcare facilities from installing robotic platforms despite the proven medical benefits, thus, hampering the market growth. Lack of definite financial benefits recognized from robot-assisted procedures has slowed adoption rates in cost-sensitive markets.

Market Opportunities: Applications of medical robotics in non-invasive surgeries

Medical robotics has immense potential in revolutionizing the field of minimally invasive surgeries. As robotics and computer technologies become more sophisticated, medical robots are increasingly being used in complex non-invasive surgical procedures with great accuracy and consistency. Robotic surgical systems have enabled doctors to perform several complex surgical procedures like organ transplants, colon cancer surgeries and repairs of brain aneurysms through small incisions instead of conventional open surgery. This significantly reduces recovery time for patients, preserves tissue integrity and minimizes surgical trauma and blood loss compared to traditional open surgeries. For example, robotic systems for colon cancer surgery have led to comparatively shorter hospital stays and fewer complications for patients, according to research studies published by leading hospitals.

To learn more about this report, request sample copy

By Product Type: Technological Advancements Drive Growth of Robotic Systems Segment

By product type, robotic systems segment is estimated to contribute the highest market share of 59.8% in 2024, due to ongoing technological advancements. Robotic systems have witnessed widespread adoption in surgery due to their ability to perform complex procedures with unmatched accuracy and minimal invasive techniques. Robot-assisted surgery provides surgeons with a high-definition 3D view of the surgical area and filters out hand tremors to ensure precision down to the millimeter. This level of precision is especially valuable for procedures like prostatectomies which require delicate maneuvering near critical organs and nerves. The da Vinci surgical system continues to be the gold standard platform, having performed over 5 million procedures globally. Ongoing software and hardware upgrades expand the system's capabilities into new therapeutic areas. For example, the latest da Vinci Xi and SP surgical platforms feature multi-quadrant anatomy visualization, augmented intelligence capabilities, and robotic arm enhancements. Their user interfaces also provide an more immersive experience that many surgeons prefer over traditional laparoscopy. Rise company is also developing MRI-compatible robotic arms to enable minimally invasive tumor resections guided by real-time MRI. Aside from surgery, robotic prosthetics have also gained popularity for rehabilitation. Manufacturers are designing exoskeletons with advanced sensors and artificial intelligence that can assist patients in regaining mobility after injury or diseases like stroke. Startups like Rewalk Robotics and Ekso Bionics have brought bionic leg devices to market that help paraplegics walk again using brain signals or crutches for support. As robotic technology continues to progress, their capabilities can boost their adoption across a wide range of medical specialties.

By End User: Expanding Patient Access Drives Hospital Segment Growth

By end user, hospitals segment is estimated to contribute the highest market share of 50.2% in 2024,  due to hospitals' role as primary points of access for surgical, rehabilitation, and acute care. The majority of robotic-assisted surgeries still occur in hospital operating rooms where specialized infrastructure and well-trained operating teams are readily available. Due to their scale, hospitals can also more readily invest in the high upfront costs of robotic platforms that are expensive. As reimbursement models evolve, more hospitals are looking to share the cost and utilization of expensive robotic equipment with ambulatory surgical centers and partner clinics. This helps expand patient access to robotic therapies while improving the return on investment for hospitals. Rehabilitation centers are also seeing increased adoption of robotic exoskeletons which help patients progress more quickly from assisted walking to full independence.

Regional Insights

To learn more about this report, request sample copy

North America has established itself as the dominant regional market for medical robotic systems with an estimated market share of 40.2% in 2024. The region enjoys strong industry presence from key players like Intuitive Surgical, Stryker and Medtronic who have their headquarters and major manufacturing facilities located in the U.S. This allows them to cater to domestic demand as well as export to other regions promptly. With a well-developed healthcare infrastructure and high healthcare expenditure, the U.S. accounts for the largest share of the regional market.

The reimbursement policies and regulatory approval processes are well-defined in North America, enabling faster uptake of new medical robotic technologies. Moreover, the availability of skilled surgeons highly trained in robot-assisted procedures has increased demand for surgical robots over the last decade. Leading hospitals in the U.S. have made huge investments to establish robot-assisted surgery departments, adopting premium robotic systems from major suppliers. Given the widespread industry presence, North America also accounts for significant manufacturing and export of medical robot parts.

Asia Pacific region has emerged as the fastest growing regional market for medical robotic systems. Rapidly improving healthcare infrastructure, policies encouraging medical tourism along with rising disposable incomes are driving heavy demand. In particular, China and Japan have strong manufacturing capabilities and represent major production and export hubs for medical robotics. With a huge patient population and lower treatment costs, countries like India and Singapore are attracting significant medical tourists opting for robot-assisted surgeries.

Market Report Scope

Key Developments

• In January 2024,EndoQuest Robotics, Revolutionizing robotic technology company and Omnivision, Semiconductor manufacturing company are teaming up to integrate advanced image sensor technology into surgical robotics. Omnivision will incorporate its OCHFA CameraCubeChip image sensor into EndoQuest's adaptable robotic system. While the robot is currently in development and awaits clearance from the US Food and Drug Administration (FDA), it has been accepted into the FDA's Safer Technologies Program (STeP).
• In June 2023, Touchlab, a deep tech robotics firm, unveiled a groundbreaking robot allowing doctors to remotely sense patients during a trial at a hospital in Finland. Controlled by operators wearing specialized gloves, the Välkky telerobot employs cutting-edge electronic skin technology to transmit tactile feedback from its robotic hand to users. Over a three-month trial at Laakso Hospital in Helsinki, a trained nurse team will evaluate how these robots can support patient care, reduce workload, and minimize infection risks.
• In September 2022, Titan Medical, a medical technology company partnered with Medtronic , healthcare technology company for a limited development initiative. Medtronic will assess the performance of Titan's cameras and instruments in gynecological procedures, anticipated as the primary application for its surgical robot.
• In June 2022, Intuitive, a global leader in robotic-assisted surgery, received USFDA clearance to integrate mobile cone-beam CT (CBCT) imaging technology with its Ion Endoluminal System for robotic-assisted bronchoscopy.
• In January 2022, Medrobotics Corp. announced FDA regulatory approval to market the Flex Robotic System for robot-assisted visualization in general surgical, gynecological, and thoracic procedures in the United States. This clearance underscores the company's advancement in developing innovative products for single-port surgeries across multiple medical disciplines.

*Definition: Medical Robotic System consists of computer-controlled robotic devices used to assist in surgical procedures and for other medical applications. These robotic systems allow for minimally invasive surgeries and can provide greater precision, flexibility and control than traditional procedures. Medical Robotic Systems may include surgical robots for tasks like suturing or remote surgery equipment that allows surgeons to operate on patients from remote locations. These robotic technologies aim to improve surgical outcomes for patients and help overcome limits of conventional techniques.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Instruments & Accessories
    • Robotic Systems
    • Surgical Robotic Systems
    • Rehabilitative Robotic System
    • Non-invasive Radiosurgery Robots
    • Hospital and Pharmacy Robotic Systems
    • Telepresence Robotic System
    • Other Robotic Systems
•  End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Rehabilitation Centers
  • Ambulatory Surgical Centers
  • Home-Care Settings
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • iRobot Corporation
  • Medrobotics Corporation
  • Titan Medical Inc.
  • Renishaw Plc
  • Health Robotics SLR
  • OR Productivity plc
  • Intuitive Surgical
  • Mako Surgical Corp.
  • Varian Medical Systems
  • Stereotaxis Inc.
  • Mazor Robotics
  • Medtronic
  • Stryker
  • Zimmer Biomet
  • Smith & Nephew